Wednesday, March 20, 2019 4:18:45 PM
The success of GW in developing pharmaceutical drugs from marijuana sent its shares from less than $9 in 2013 to more than $110 in 2016 and earned it a market value of more than $2.9 billion. And has almost doubled again.
I believe the Zynerba Pharma pipeline is comparable and as deep as GWPH. Exciting times ahead.
Armando the CEO has sold two other biotech companies for north of a billion each.
No Debt
60 Million in cash
The 21 million shares makes ZYNE shares very scarce and the possibility for a blue sky break out in the near future many catalysts.
http://ir.zynerba.com/static-files/1a4c0483-3e61-43d7-a160-ddfc45f68b64
Long
$ZYNE
&
$GWPH
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM